H.R. 4400 · 116th Congress
Advancing Education on Biosimilars Act of 2019
- Stage
- In committee
- Sponsor
- Larry Bucshon
- Introduced
- 2019-09-19
- Latest action
- 2019-09-20 · Referred to the Subcommittee on Health.
Summary
Advancing Education on Biosimilars Act of 2019This bill requires the Department of Health and Human Services (HHS) to maintain a website and undertake other activities to educate health care providers, patients, and caregivers about biological products, biosimilar biological products, and interchangeable biosimilar biological products.
Among other activities, HHS must develop or improve continuing education programs that address clinical considerations for biological and related products. Health care providers eligible for the Merit-based Incentive Payment System in Medicare may count completion of such a program as a clinical practice improvement activity.